We are live on ! Find out more
ADMA icon

ADMA Biologics

13 hedge funds and large institutions have $66.8M invested in ADMA Biologics in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$40.3M +$41.3M +3,608,171 New
CCM
2
Consonance Capital Management
New York
$9.8M +$10M +877,407 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$4.73M +$4.84M +423,100 New
BC
4
Broadfin Capital
New York
$4.35M +$4.45M +389,193 New
Franklin Resources
5
Franklin Resources
California
$4.02M +$4.12M +360,137 New
SCM
6
Sio Capital Management
New York
$2.75M +$2.81M +245,930 New
TI
7
Telemetry Investments
New York
$749K +$767K +67,066 New
US Bancorp
8
US Bancorp
Minnesota
$22K +$22.9K +2,000 New
PCM
9
Prelude Capital Management
New York
$18K +$18.3K +1,600 New
Morgan Stanley
10
Morgan Stanley
New York
$7K +$7.62K +666 New
RC
11
RegentAtlantic Capital
New Jersey
$5.58K +$5.72K +500 New
TRCT
12
Tower Research Capital (TRC)
New York
$2K +$2.29K +200 New
Citigroup
13
Citigroup
New York
+$34 +3 New